Israeli Parkinson’s treatment is used in 40 countries

Japan’s Takeda has signed a deal to commercialize Teva’s innovative treatment for Parkinson’s disease, rasagiline, for use in Japan. It follows Takeda’s deal in Dec 2013 to develop Teva’s glatiramer acetate for the treatment of multiple sclerosis.
http://www.globes.co.il/en/article-takeda-to-sell-teva-parkinsons-treatment-in-japan-1000934433

This entry was posted in Israel's Medical Achievements. Bookmark the permalink.

Leave a Reply

Your email address will not be published.